BiotechTube
Klona Biotech

Klona Biotech

London, United Kingdom· Est.
klonabiotech.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $2.5M

Overview

Klona Biotech is an early-stage, private biotech firm specializing in tissue engineering and regenerative medicine. Founded in 2020, the company is likely in a pre-clinical or research phase, developing a platform to engineer biological tissues for therapeutic applications. As a pre-revenue entity, it will be reliant on venture capital and grants to fund its R&D. Its success hinges on validating its technology platform, advancing a pipeline, and navigating the complex regulatory pathway for engineered tissues.

Regenerative MedicineTissue Engineering

Technology Platform

Likely integrates biomaterials, cell biology (potentially stem cells), and bioreactor systems to engineer functional biological tissues for implantation or disease modeling.

Funding History

1
Total raised:$2.5M
Seed$2.5M

Opportunities

The global tissue engineering market is large and growing, driven by unmet needs in organ failure, chronic wounds, and musculoskeletal disorders.
Success could lead to curative, high-value therapies and potential platform applications in drug discovery.

Risk Factors

Faces major technical hurdles in tissue vascularization and scalability, a complex and costly regulatory pathway for advanced therapies, and reliance on continuous venture funding in a competitive landscape.

Competitive Landscape

Competes with other biotech startups in regenerative medicine, as well as large pharmaceutical and medical device companies developing cell and tissue-based therapies. Differentiation will depend on proprietary platform technology and execution speed.

More companies in United Kingdom →